Risk of diabetic retinopathy and diabetic macular oedema with sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes: a real-world data study from a global federated database
Eleftheriadou A, Riley D, Zhao SS, et al.
Diabetologia. Pub. Online 8 Apr 2024.
Leggi